ALLMedicine™ Burkitt Lymphoma Center

Feb 26th, 2021 - In the immunocompromised setting, recipients of solid-organ or hematopoietic stem-cell transplants carry an increased risk of post-transplant lymphoproliferative disorder (PTLD). Burkitt lymphoma (BL) PTLD is a rare form of monomorphic B-cell PTLD...

Feb 23rd, 2021 - Histiocytic sarcoma arising in a child affected by Burkitt lymphoma, with t(8;14)(q24;q32) positivity in both tumors.|2021|d'Amore ESG,Mainardi C,Mussolin L,Carraro E,Alaggio R,|

Feb 21st, 2021 - Type A lactic acidosis is a potentially life-threatening complication in critically ill patients and is the hallmark of a shock state as a result of tissue hypoperfusion and dysoxia. Type B lactic acidosis results from mechanisms other than dysoxi...

Feb 18th, 2021 - Cutaneous Involvement of Erdheim-Chester Disease in a Patient with Burkitt Lymphoma.|2021|Buckley K,Baiocchi RA,Kaffenberger B,Chung CG,|

Feb 17th, 2021 - We investigated the clinical characteristics and outcomes of acquired immunodeficiency syndrome-related Burkitt lymphoma (AIDS-BL). A single-center retrospective study was performed of 78 cases over a 10-year period. The baseline characteristics o...

Nov 29th, 2012 - Treatment recommendations for endemic Burkitt lymphoma (BL) in settings with only minimum requirements for curative treatment (PODC setting 1) are described. The reported cure rate for endemic BL is usually <50%. Facilities within setting 1 differ...

Feb 26th, 2021 - In the immunocompromised setting, recipients of solid-organ or hematopoietic stem-cell transplants carry an increased risk of post-transplant lymphoproliferative disorder (PTLD). Burkitt lymphoma (BL) PTLD is a rare form of monomorphic B-cell PTLD...

Feb 24th, 2021 - To complement The ASCO Post’s continued comprehensive coverage of the 2020 American Society of Hematology (ASH) Annual Meeting & Exposition, here are several abstracts selected from the meeting proceedings focusing on the assessment and treatment ...

Feb 23rd, 2021 - Histiocytic sarcoma arising in a child affected by Burkitt lymphoma, with t(8;14)(q24;q32) positivity in both tumors.|2021|d'Amore ESG,Mainardi C,Mussolin L,Carraro E,Alaggio R,|

Feb 21st, 2021 - Type A lactic acidosis is a potentially life-threatening complication in critically ill patients and is the hallmark of a shock state as a result of tissue hypoperfusion and dysoxia. Type B lactic acidosis results from mechanisms other than dysoxi...

Feb 18th, 2021 - Cutaneous Involvement of Erdheim-Chester Disease in a Patient with Burkitt Lymphoma.|2021|Buckley K,Baiocchi RA,Kaffenberger B,Chung CG,|

Feb 8th, 2021 - NEW YORK (Reuters Health) - An international team has developed and validated a prognostic index specific for Burkitt lymphoma to aid in risk stratification, interpretation of clinical trials, and targeted development of novel therapeutic strategi...

Jun 10th, 2020 - Adult patients with Burkitt lymphoma can achieve equally sound survival outcomes with dose-adjusted chemotherapy vs high-intensity regimens, but can do so while avoiding the severe toxicities, US study data shows. Although Burkitt lymphoma is the ...

Jan 14th, 2020 - The National Comprehensive Cancer Network (NCCN) has released its first set of guidelines for managing pediatric aggressive mature B-cell lymphomas. The guidelines highlight the complexities of treating pediatric Burkitt lymphoma (BL) and diffuse.

Mar 7th, 2019 - Burkitt-like lymphoma with 11q aberration (BLL-11q) is not very “Burkitt-like,” according to researchers. They found that BLL-11q has a genomic and mutational profile more closely related to that of high grade B-cell lymphoma (HGBCL) or diffuse la.

Aug 19th, 2018 - Some viruses are implicated in the pathogenesis of NHL, probably because of their ability to induce chronic antigenic stimulation and cytokine dysregulation, which leads to uncontrolled B-cell or T-cell stimulation, proliferation, and lymphomagene...